70.48
price up icon2.56%   1.76
after-market Handel nachbörslich: 70.87 0.39 +0.55%
loading
Schlusskurs vom Vortag:
$68.72
Offen:
$69.422
24-Stunden-Volumen:
3.12M
Relative Volume:
0.71
Marktkapitalisierung:
$218.58B
Einnahmen:
$54.98B
Nettoeinkommen (Verlust:
$7.77B
KGV:
28.31
EPS:
2.49
Netto-Cashflow:
$9.14B
1W Leistung:
+0.23%
1M Leistung:
+0.76%
6M Leistung:
+3.34%
1J Leistung:
-10.97%
1-Tages-Spanne:
Value
$69.42
$70.54
1-Wochen-Bereich:
Value
$68.61
$70.69
52-Wochen-Spanne:
Value
$61.24
$87.67

Astrazeneca PLC Stock (AZN) Company Profile

Name
Firmenname
Astrazeneca PLC
Name
Telefon
44 20 3749 5000
Name
Adresse
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
Name
Mitarbeiter
61,100
Name
Twitter
@AstraZeneca
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
AZN's Discussions on Twitter

Vergleichen Sie AZN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Major icon
AZN
Astrazeneca PLC
70.48 218.02B 54.98B 7.77B 9.14B 2.49

Astrazeneca PLC Stock (AZN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-15 Eingeleitet Exane BNP Paribas Outperform
2025-02-13 Hochstufung UBS Neutral → Buy
2025-02-12 Eingeleitet Morgan Stanley Overweight
2024-11-20 Hochstufung UBS Sell → Neutral
2024-11-06 Hochstufung Deutsche Bank Sell → Hold
2024-09-13 Herabstufung Deutsche Bank Hold → Sell
2024-05-30 Eingeleitet Goldman Buy
2024-04-16 Hochstufung Deutsche Bank Sell → Hold
2024-02-08 Herabstufung Deutsche Bank Hold → Sell
2024-01-23 Eingeleitet Morgan Stanley Overweight
2024-01-16 Fortgesetzt UBS Sell
2024-01-03 Herabstufung Jefferies Buy → Hold
2023-12-18 Eingeleitet HSBC Securities Buy
2023-09-25 Hochstufung Jefferies Hold → Buy
2023-07-14 Eingeleitet HSBC Securities Buy
2023-07-12 Hochstufung UBS Neutral → Buy
2023-07-05 Herabstufung Deutsche Bank Buy → Hold
2023-04-11 Hochstufung Morgan Stanley Equal-Weight → Overweight
2023-01-05 Eingeleitet BMO Capital Markets Outperform
2022-09-15 Herabstufung Credit Suisse Outperform → Neutral
2022-09-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-08-29 Hochstufung Argus Hold → Buy
2022-06-14 Herabstufung UBS Buy → Neutral
2022-02-11 Hochstufung DZ Bank Sell → Hold
2021-12-07 Herabstufung Jefferies Buy → Hold
2021-08-12 Fortgesetzt JP Morgan Overweight
2021-04-12 Herabstufung Argus Buy → Hold
2021-03-16 Hochstufung Jefferies Hold → Buy
2021-02-25 Hochstufung UBS Neutral → Buy
2021-01-15 Eingeleitet Deutsche Bank Buy
2020-12-07 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-11-30 Hochstufung UBS Sell → Neutral
2020-11-11 Hochstufung HSBC Securities Reduce → Hold
2020-09-29 Eingeleitet Berenberg Buy
2019-11-22 Eingeleitet SVB Leerink Outperform
2019-10-25 Hochstufung Liberum Hold → Buy
2019-04-02 Herabstufung UBS Neutral → Sell
2019-02-05 Eingeleitet Exane BNP Paribas Outperform
2019-01-25 Hochstufung Shore Capital Hold → Buy
2018-12-11 Fortgesetzt Jefferies Hold
2018-10-09 Eingeleitet Guggenheim Buy
2018-08-16 Herabstufung Jefferies Buy → Hold
2018-03-19 Hochstufung Jefferies Hold → Buy
2018-02-06 Bestätigt Leerink Partners Mkt Perform
2018-02-05 Bestätigt Bernstein Outperform
2018-01-18 Bestätigt Leerink Partners Mkt Perform
2017-12-29 Hochstufung JP Morgan Neutral → Overweight
2017-10-16 Hochstufung Credit Suisse Neutral → Outperform
2017-09-25 Hochstufung Exane BNP Paribas Neutral → Outperform
2017-09-22 Hochstufung Bernstein Mkt Perform → Outperform
Alle ansehen

Astrazeneca PLC Aktie (AZN) Neueste Nachrichten

pulisher
05:43 AM

AstraZeneca vows to spend US$50bil on US manufacturing boost - thestar.com.my

05:43 AM
pulisher
05:04 AM

AstraZeneca Pledges Big Investment In US Manufacturing Amid Tariff Threats - insights.citeline.com

05:04 AM
pulisher
03:14 AM

AstraZeneca commits $50 billion to US pharmaceutical manufacturing and R&D - BioProcess International

03:14 AM
pulisher
02:15 AM

Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - Benzinga

02:15 AM
pulisher
02:09 AM

Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy - Benzinga

02:09 AM
pulisher
01:05 AM

AstraZeneca to invest $50 bn in the US as tariff threat looms - Yahoo.co

01:05 AM
pulisher
12:23 PM

AstraZeneca to invest $50B in US to boost drug manufacturing and R&D - Proactive financial news

12:23 PM
pulisher
12:12 PM

AstraZeneca’s Phase 2 Study on Trastuzumab Deruxtecan: A Potential Game-Changer in Cancer Treatment - TipRanks

12:12 PM
pulisher
12:07 PM

AstraZeneca’s New Trial: A Step Forward in Liver Fibrosis Treatment? - TipRanks

12:07 PM
pulisher
12:05 PM

Fear of tariffs? AstraZeneca calls $50 billion US investment a ‘deliberate choice’ - Euractiv

12:05 PM
pulisher
12:05 PM

AstraZeneca’s Tozorakimab Study: A Potential Game-Changer in COPD Treatment - TipRanks

12:05 PM
pulisher
12:02 PM

AstraZeneca’s Phase 4 Study on Tezepelumab: A Boost for Severe Asthma Treatment - TipRanks

12:02 PM
pulisher
11:43 AM

AZN Commits USD50B to US Manufacturing Expansion Amid Tariff Pressures - TradingView

11:43 AM
pulisher
10:00 AM

AstraZeneca picks Virginia for multibillion-dollar manufacturing site - Richmond Times-Dispatch

10:00 AM
pulisher
09:33 AM

Lockheed Martin, AstraZeneca, DR Horton: Trending Tickers - Yahoo Finance

09:33 AM
pulisher
07:56 AM

Astrazeneca, Phillip Morris & D.R. Horton earnings: Trending Tickers - Yahoo.co

07:56 AM
pulisher
06:51 AM

AstraZeneca announces $50 billion US investment in manufacturing and R&D By Investing.com - Investing.com Australia

06:51 AM
pulisher
06:37 AM

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D July 22, 2025 - James Sharp & Co.

06:37 AM
pulisher
06:33 AM

AZN to invest $50bn in US, targets $80bn revenue by 2030 | AZN SEC FilingForm 6-K - Stock Titan

06:33 AM
pulisher
06:00 AM

Global pharma companies do record deals with Chinese biotechs - Financial Times

06:00 AM
pulisher
05:38 AM

Trending tickers: AstraZeneca, Verizon, Opendoor, Trump Media and Lindt & Spruengli - Yahoo.co

05:38 AM
pulisher
05:34 AM

AstraZeneca unveils $50 billion US investment as pharma tariff threat looms - Reuters

05:34 AM
pulisher
05:32 AM

Astra Pledges $50 Billion on US Manufacturing, Development - Bloomberg.com

05:32 AM
pulisher
04:41 AM

AstraZeneca PLC (AZN)’s Datroway Wins FDA Nod for Lung Cancer Breakthrough - MSN

04:41 AM
pulisher
04:25 AM

AstraZeneca announces $50bn US investment in manufacturing and R&D - Proactive financial news

04:25 AM
pulisher
04:19 AM

AstraZeneca unveils plans for £37bn investment in US amid tariff threats - Yahoo.co

04:19 AM
pulisher
04:10 AM

AstraZeneca to invest $50bn in the US amid fears it could quit Britain - The Telegraph

04:10 AM
pulisher
04:03 AM

AstraZeneca pledges $50bn in US investment as Trump pharma tariffs loom - Financial Times

04:03 AM
pulisher
03:51 AM

AstraZeneca Vows to Spend $50 Billion on US Manufacturing, Development - MSN

03:51 AM
pulisher
03:17 AM

AstraZeneca to invest $50bn in US after Trump tariff threat - The Times

03:17 AM
pulisher
02:48 AM

Astrazeneca plots huge $50bn US investment after ditching UK expansion plans - Yahoo.co

02:48 AM
pulisher
02:41 AM

AstraZeneca says to invest $50 bn in the US - Yahoo.co

02:41 AM
pulisher
Jul 21, 2025

AstraZeneca To Invest $50 Bln In U.S. By 2030 To Boost Medicine Production And Research - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca vows to spend $50 billion on US manufacturing, development - CNBC TV18

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca grows US presence with $50B in spending plans - BioPharma Dive

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca pledges $50 bln investment in US as pharma tariffs loom By Investing.com - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca to invest $50B in US economy by 2030 - AOL.com

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca to invest $50B in US by 2030 - breakingthenews.net

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca to spend $50-billion to expand manufacturing, research capabilities in U.S. - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

What analysts say about AstraZeneca PLC Depositary Receipt stockPowerful profit generation - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca’s Observational SLE Study in Kazakhstan: Key Insights for Investors - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca Plans Massive $50B US Investment: New Virginia Mega-Factory to Create Thousands of Jobs - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca’s Promising Pediatric SLE Study: Anifrolumab’s Potential Impact - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca’s New Phase II Study: A Potential Breakthrough in Liver Cancer Treatment - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca’s COPD Study: Potential Game-Changer for Cardiopulmonary Outcomes - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca’s AIRSUPRA Study: A Potential Game-Changer in Asthma Treatment - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

What drives AstraZeneca PLC Depositary Receipt stock priceRapid wealth multiplication - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca reports positive results from Tagrisso combo trial - Seeking Alpha

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca Bets Big On America With $50B Investment, New Virginia Hub Plans Amid Pharma Tariff Jitters - Stocktwits

Jul 21, 2025
pulisher
Jul 21, 2025

AstraZeneca’s lung cancer drug shows improved survival with chemotherapy combo - Investing.com UK

Jul 21, 2025

Finanzdaten der Astrazeneca PLC-Aktie (AZN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
Kapitalisierung:     |  Volumen (24h):